Risk factor
Good trading liquidity
Profitability factor
Overvalued vs peers
About
Guangzhou Wondfo Biotech Co.,Ltd, a biological company, engages in the research and development, production, and sale of point-of-care testing products, and rapid diagnosis and chronic disease management solutions. The company offers rapid test kits for COVID-19, drug of abuse, tumor, infectious, fertility, and sexually transmitted diseases, as well as immunofluorescence devices to detect cardiovascular diseases,...
Company Valuation
Considering past and projected metrics, the stock is 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBITDA, overval
Target Price
The average target price of 300482.SZ is 27 and suggests 30% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc
Buy
Sell